The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) to Becton, Dickinson and Company (BD) for its BD Vacutainer Plus Citrate Plasma Tubes.
These are sodium-citrate blood-specimen collection tubes used to collect, transport, and store blood samples for coagulation testing.
The FDA said the tubes authorized under the EUA are for use in coagulation testing, performed by authorized laboratories, to aid in the identification and treatment of coagulopathy in patients, including patients with known or suspected COVID-19.
